Drug Therapy And Interactions In Pediatric Oncology

There are few publications about drug interactions in chemotherapy and even less about pediatric oncology treatment. For this reason, the present book is intended to offer guidelines about drug interactions for physicians, pharmacists and the other healthcare professionals involved in the chemotherapy of pediatric patients. In this book the reader will have access to a primary introduction for the major diseases in pediatric oncology, followed by the major therapeutic protocols. Following that, the most important drug interactions in pediatric oncology treatment are presented and discussed in detail. Finally, important topics such as Drug-Food Interactions are addressed. Drug Therapy and Interactions in Pediatric Oncology focuses in great detail on the drug interactions in Pediatric Oncohematology and will be an indispensable resource in daily practice for a wide range of health providers.

This book provides a comprehensive overview of pediatric oncology, discussing drug therapy and treatment in children under the age of 1 year. It is the first volume to focus on chemotherapy in newborns and infants, especially the daily clinical practice and treatment protocols. Intended as a practical manual, it addresses all the major topics related to pediatric oncology in an accessible and easy-to-use format. It examines topics in pediatric oncology therapeutics, including drug metabolism, excretion, toxicity, drugs that can be used for each week or month of the patient’s life, dose adjustment and treatment protocols.Chemotherapy in Neonates and Infants focuses on the safe treatment of children in the first year of life, and is aimed at pediatric oncology/hematology institutions, clinics and departments. It is particularly valuable for researchers, pediatric oncology physicians, pediatric and neonatology physicians, oncology pharmacists and the other healthcare professionals directly involved in the chemotherapy of neonates and infants.

There are few publications about chemotherapy in children, and none of them is a book aimed at pharmacists. Pediatric Oncology Pharmacy is an area where more and more specific knowledge is required in daily practice. Pharmacists who work in pediatric oncology area do not have a book directed at them; none of the oncopediatric books addresses topics unique to pharmacy — such as manipulation of cytotoxic drugs for children, analysis of oncopediatric prescriptions, clinical pharmacy in oncopediatrics, pharmaceutical care in oncopediatric area, and other subjects that are of exclusive interest to these professionals, but no less essential for a therapy of excellence. As for this need, the purpose of this book is to be a guideline for all subjects that pediatric oncology pharmacists need to know to work in this area. It will be an essential guide to pediatric oncology pharmacists, clinical pharmacists, pharmaceutical residents who work with drug therapy in children and pharmaceutical researchers. It will be a pocket guide to assist in daily practice, and it will be essential to Pediatric Oncology/ Hematology Institutions. The essential propose of this book is to be the first one focusing pediatric oncology for pharmacists.

There are few publications about drug interactions in chemotherapy and even less about pediatric oncology treatment. For this reason, the present book is intended to offer guidelines about drug interactions for physicians, pharmacists and the other healthcare professionals involved in the chemotherapy of pediatric patients. In this book the reader will have access to a primary introduction for the major diseases in pediatric oncology, followed by the major therapeutic protocols. Following that, the most important drug interactions in pediatric oncology treatment are presented and discussed in detail. Finally, important topics such as Drug-Food Interactions are addressed. Drug Therapy and Interactions in Pediatric Oncology focuses in great detail on the drug interactions in Pediatric Oncohematology and will be an indispensable resource in daily practice for a wide range of health providers.

This book covers a broad spectrum of complementary and alternative medicine (CAM) practices employed in pediatric oncology worldwide, with a special focus on the methods widely used in Western countries. It is a scientifically based, practice-oriented handbook that will meet the needs of pediatric oncologists working in medical practices and hospitals. An introductory section includes a comparative overview of current CAM use in pediatric oncology in different countries. Commonly used CAM methods are then discussed in a series of chapters that provide a theoretical description of the method in question, followed by more practically oriented information, including scientific data if applicable. Special attention is paid to the issue of how to integrate each method into conventional pediatric oncology. The closing parts of the book consider aspects of CAM requiring further development, such as institutional research, and provide a road map on establishing integrative pediatric oncology worldwide.

Three of every four children and adolescents with cancer can now be cured. However, physicians are using increasingly intensive treatment regimens. These treatments can expose patients to toxic chemotherapeutic agents, invasive surgical procedures, and radiation oncology interventions that risk disfigurement, neuropsychiatric damage, and life-threatening organ toxicity. These potentially dire consequences have mandated that advances in cancer treatment go hand in hand with supportive care measures that sustain patients through their therapeutic ordeal and allow each patient to achieve maximum quality of life. In this book, now in its third edition, the discipline of supportive care in pediatric oncology is covered in depth. Supportive Care of Children with Cancer is a ready-reference handbook designed for use at the hospital bedside, in the oncology outpatient clinic, or in the physician's office. To create this book, leading experts in the field recommended approaches to supportive care which were then critically reviewed by members of the Children's Oncology Group, the world's largest cooperative study group for children's cancer. For students, house officers, fellows, pediatric oncologists, surgeons, nurses, nutritionists, social workers, and psychologists, this book provides essential information about the care of pediatric oncology patients. The third edition features a new chapter on recognition, prevention, and remediation of burnout in pediatric oncology staff members, while throughout the book, chapters have been revised and updated to reflect the impact of new antibiotic agents, new antiemetics, and new approaches to pain management.

The successes that have been achieved in treating childhood cancers stand as beacons against the less dramatic improvements for adults with cancer. Progress began to accelerate in the 1960s and 1970s, as treatment regimens were built up, primarily by building combinations of chemotherapeutic drugs. However the near absence of research in pediatric cancer drug discovery threatens to halt the progress in childhood cancer treatment achieved during the past four decades. Making Better Drugs for Children with Cancer identifies the major issues to be addressed in developing new agents for childhood cancers, the gaps in research and development, and the steps that have been suggested to move the process forward. This report also makes a new proposal to capitalize on today's science to bring new treatments to children's cancers.

The dramatic improvement made in recent years in the treatment of child hood malignancies has been in large part the result of advances in the field of pharmacology. Chemotherapy is the major therapeutic modality used to treat childhood cancer. Rational administration of antineoplastic chemo therapy to the child with cancer requires the pediatric oncologist to have a thorough understanding of the fundamental principles of clinical pharmaco logy, an intimate knowledge of the specific agents being used, and an aware ness of the unique biologic and physiologic features of children. In mid 1985, a distinguished group of pediatric oncologists and clinical pharmacologists convened in a unique workshop to review the subject of pharmacology in pediatric oncology. A goal of this workshop was to pro duce a book which would review this topic and present it in a format useful for the clinician. In this book basic principles of pharmacology, mechanisms of drug resis tance, new methods of drug delivery, guidelines for studying new agents in children, new biological response modifiers and the pharmacology of the most commonly used chemotherapeutic agents in children are reviewed in depth. Particular emphasis is given to discussing those topics which unique ly apply to the use of antineoplastic agents in children with cancer. The Editors VII Contents Preface . v Contents Vll List of Major Contributors Xl Principles of Antineoplastic Therapy in Children 1. Clinical pharmacokinetics for the pediatric oncologist ................ .

This convenient handbook gives you instant access to current, clinically relevant drug information. You'll find complete drug monographs for more than 100 drugs, plus separate units on pediatric oncology, supportive care, and drug interactions. In addition, special nursing considerations highlight your specific role and responsibility with respect to administration, patient monitoring, and patient education for each drug. A companion Evolve® website gives you quarterly updates, web links, formulas, and IV compatibilities. Full monographs provide crucial information you need for more than 100 of the most commonly used drugs in oncology practice and include Clinical Pharmocology, Safe Handling issues, Adverse Reactions, Unlabeled Uses, and Y-site Compatibles. Entire Pediatric Oncology unit focuses on considerations specific to pediatric patients. Supportive Care sections help you manage your patients' symptoms and side effects. Easy-to-use tables equip you with drug interactions for over 66 anticancer drugs. 13 preventive rules help you avoid medication errors. Occupational Exposures to Hazardous Drugs unit teaches you to assess risk, implement protective measures, and monitor hazardous agents. Color insert contains images of the pathophysiology of chemotherapy-induced emesis, oral mucosa and phases of mucositis, normal bone remodeling, and a cross-sectional diagram of vertebral column structures and corresponding metastases. Appendices provide you with quick reference for formulas, chemotherapy regimes and drug information on the web, patient assistance programs, and newly approved drugs in abbreviated monograph format. Flexible, water-resistant cover stands up to daily use on the job. Evolve Resources, free with qualified adoptions, include quarterly online updates with the latest information on newly approved drugs and indications, as well as commonly used formulas, IV compatibilities, and weblinks. PDA feature available with separate purchase allows you to download the entire handbook to a PDA device for easy-to-use navigation and search capability.